Follow
Martti Kulvik
Martti Kulvik
Chief Research Scientist, Etlatieto Ltd, Etla
Verified email at etla.fi
Title
Cited by
Cited by
Year
Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine
H Joensuu, L Kankaanranta, T Seppälä, I Auterinen, M Kallio, M Kulvik, ...
Journal of neuro-oncology 62, 123-134, 2003
2662003
Atomic emission method for total boron in blood during neutron-capture therapy
J Laakso, M Kulvik, I Ruokonen, J Vahatalo, R Zilliacus, M Farkkila, ...
Clinical chemistry 47 (10), 1796-1803, 2001
892001
International mega-trends and growth prospects of the Finnish biotechnology industry: Recent economic research and policy implications
R Hermans, M Kulvik, P Ylä-Anttila
Journal of Commercial Biotechnology 11, 134-145, 2005
362005
Rakennusalan kilpailukyky ja rakentamisen laatu Suomessa
A Ahonen, J Juha-Matti, J Puhto, J Ali-Yrkkö, A Avela, M Kulvik, T Kuusi, ...
valtioneuvoston kanslia, 2020
332020
Biokinetic analysis of tissue boron (10B) concentrations of glioma patients treated with BNCT in Finland
H Koivunoro, E Hippeläinen, I Auterinen, L Kankaanranta, M Kulvik, ...
Applied Radiation and Isotopes 106, 189-194, 2015
322015
Non-linear model for the kinetics of 10B in blood after BPA–fructose complex infusion
P Ryynänen, A Kangasmäki, P Hiismäki, J Coderre, AZ Diaz, M Kallio, ...
Physics in Medicine & Biology 47 (5), 737, 2002
302002
Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET
K Havu-Aurén, J Kiiski, K Lehtiö, O Eskola, M Kulvik, V Vuorinen, ...
European Journal of Nuclear Medicine and Molecular Imaging 34, 87-94, 2007
262007
Clinical implementation of 4-dihydroxyborylphenylalanine synthesised by an asymmetric pathway
M Kulvik, J Vähätalo, E Buchar, M Färkkilä, E Järviluoma, J Jääskeläinen, ...
European journal of pharmaceutical sciences 18 (2), 155-163, 2003
222003
The Finnish boron neutron capture therapy program–an overview on scientific projects
S Savolainen, I Auterinen, M Kallio, M Kärkkäinen, A Kosunen, C Aschan, ...
Advances in Neutron Capture Therapy, International Congress Series 1132, 342-347, 1997
201997
Patent citations indicating present value of the biotechnology business
T Nikulainen, R Hermans, M Kulvik
International Journal of Innovation and Technology Management 5 (03), 279-301, 2008
192008
Survey on the Finnsh biotechnology industry: Background and descriptive statistics
R Hermans, M Kulvik, AJ Tahvanainen
ETLA Discussion Papers, 2005
152005
Survey on the Finnsh biotechnology industry: Background and descriptive statistics
R Hermans, M Kulvik, AJ Tahvanainen
ETLA Discussion Papers, 2005
152005
Measuring intellectual capital and sources of equity financing–value platform perspective within the Finnish biopharmaceutical industry
R Hermans, M Kulvik
International Journal of Learning and Intellectual Capital 1 (3), 282-303, 2004
132004
Large animal model for healthy tissue tolerance study in BNCT
J Benczik, T Seppälä, J Hopewell, M Snellman, I Auterinen, R Joensuu, ...
Frontiers in Neutron Capture Therapy: Volume 1, 1233-1238, 2001
132001
On-line boron-10 determination from blood samples by ICP-MS
M Kulvik, J Laakso, J Vähätalo, R Zilliacus
Frontiers in Neutron Capture Therapy: Volume 1, 849-851, 2001
122001
Boron biodistribution in Beagles after intravenous infusion of 4-dihydroxyborylphenylalanine–fructose complex
ME Kulvik, JK Vähätalo, J Benczik, M Snellman, J Laakso, R Hermans, ...
Applied radiation and isotopes 61 (5), 975-979, 2004
112004
First clinical results on the Finnish study on BPA-mediated BNCT in glioblastoma
L Kankaanranta, T Seppälä, M Kallio, J Karila, C Aschan, T Serén, ...
9th International Symposium on Neutron Capture Therapy for Cancer: NCT Osaka …, 2000
112000
The biotechnology industry in Finland
R Hermans, M Kulvik, AJ Tahvanainen
2006): Sustainable Biotechnology Development–New Insights into Finland, ETLA …, 2006
92006
E-Services and Productivity
O Martikainen, M Kulvik, V Naumov
Information Technologies and Control 10 (3), 2-8, 2011
82011
How general are general purpose technologies? Evidence from nano-, bio-and ICT-technologies in Finland
T Nikulainen, M Kulvik
ETLA Discussion Papers, 2009
82009
The system can't perform the operation now. Try again later.
Articles 1–20